Cargando…
336 Risks of COVID-19 infection and mortality for patients on biologics
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053931/ http://dx.doi.org/10.1016/j.jid.2021.02.358 |
| _version_ | 1783680217808633856 |
|---|---|
| author | Pahalyants, V. Murphy, W. Klebanov, N. Theodosakis, N. Klevens, M. Lilly, E. Asgari, M. Semenov, Y. |
| author_facet | Pahalyants, V. Murphy, W. Klebanov, N. Theodosakis, N. Klevens, M. Lilly, E. Asgari, M. Semenov, Y. |
| author_sort | Pahalyants, V. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8053931 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80539312021-04-19 336 Risks of COVID-19 infection and mortality for patients on biologics Pahalyants, V. Murphy, W. Klebanov, N. Theodosakis, N. Klevens, M. Lilly, E. Asgari, M. Semenov, Y. J Invest Dermatol Patient Population Research Published by Elsevier Inc. 2021-05 2021-04-19 /pmc/articles/PMC8053931/ http://dx.doi.org/10.1016/j.jid.2021.02.358 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Patient Population Research Pahalyants, V. Murphy, W. Klebanov, N. Theodosakis, N. Klevens, M. Lilly, E. Asgari, M. Semenov, Y. 336 Risks of COVID-19 infection and mortality for patients on biologics |
| title | 336 Risks of COVID-19 infection and mortality for patients on biologics |
| title_full | 336 Risks of COVID-19 infection and mortality for patients on biologics |
| title_fullStr | 336 Risks of COVID-19 infection and mortality for patients on biologics |
| title_full_unstemmed | 336 Risks of COVID-19 infection and mortality for patients on biologics |
| title_short | 336 Risks of COVID-19 infection and mortality for patients on biologics |
| title_sort | 336 risks of covid-19 infection and mortality for patients on biologics |
| topic | Patient Population Research |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053931/ http://dx.doi.org/10.1016/j.jid.2021.02.358 |
| work_keys_str_mv | AT pahalyantsv 336risksofcovid19infectionandmortalityforpatientsonbiologics AT murphyw 336risksofcovid19infectionandmortalityforpatientsonbiologics AT klebanovn 336risksofcovid19infectionandmortalityforpatientsonbiologics AT theodosakisn 336risksofcovid19infectionandmortalityforpatientsonbiologics AT klevensm 336risksofcovid19infectionandmortalityforpatientsonbiologics AT lillye 336risksofcovid19infectionandmortalityforpatientsonbiologics AT asgarim 336risksofcovid19infectionandmortalityforpatientsonbiologics AT semenovy 336risksofcovid19infectionandmortalityforpatientsonbiologics |